Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Gram-Negative Pathogens in Makkah, Saudi Arabia
- PMID: 36475249
- PMCID: PMC9692147
- DOI: 10.4314/ejhs.v32i6.20
Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Gram-Negative Pathogens in Makkah, Saudi Arabia
Abstract
Background: This study aimed to determine the prevalence of extended-spectrum-beta-lactamase (ESBL) and carbapenem-resistant gram-negative bacteria (GNB) isolated from patients at the King Faisal Hospital in Makkah, Saudi Arabia.
Methods: In this cross-sectional study, a total of 298 patients admitted to the intensive care unit for 48 hours and who had a central venous catheter were selected using a census sampling method. Only patients with ESBL and carbapenem-resistant GNB-isolated organisms (175 patients) were included. The susceptibility test of GNB was carried out according to the standard recommendations. The identified strains were tested in-vitro against several antimicrobial drugs. Statistical analysis was performed using SPSS version 24.
Results: 36(20.6%) of samples were ESBL-producing GNB, whereas 139(79.4%) were carbapenem-resistant GNB. The pooled proportional estimates of ESBL-producing GNB Escherichia coli, Klebsiella pneumoniae, and other GNB were 44.4%, 41.6%, and 14.0%, respectively; the pooled proportional estimates of carbapenem resistance GNB Klebsiella pneumoniae, Acinetobacter baumannii complex/hemolyticus and other GNB were 82.8%, 10.8%, and 6.4%, respectively. All ESBL-producing GNB and carbapenem-resistance GNB were multidrug-resistant pathogens. The highest carbapenem resistance GNB 139(100%) was to ampicillin, and the lowest 122(87.7%) was to Amoxicillin/clavulanic acid (Amox/clav). All ESBL-producing GNB 36 (100%) were resistant to cefotaxime, and 35 (97.2%) were resistant to ampicillin, cefuroxime, cefepime, and ceftazidime. Additionally, the effective antibiotic against ESBL-producing GNB was imipenem.
Conclusion: Antibiotic utilization measures appear to contribute to the control of the emergence of multidrug-resistant pathogens such as ESBL and carbapenem-resistant GNB. Strict adherence to well-accepted infection control guidelines along with caution in using broad-spectrum antimicrobial agents represents the best strategy for preventing the emergence and spread of multidrug-resistant pathogens.
Keywords: Carbapenem; Extended-spectrum beta-lactamase; Gram-negative bacteria; Resistant; Saudi Arabia.
© 2022 Kabrah A.
Similar articles
-
Extended-spectrum β-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya.Ann Clin Microbiol Antimicrob. 2023 Oct 14;22(1):91. doi: 10.1186/s12941-023-00641-8. Ann Clin Microbiol Antimicrob. 2023. PMID: 37838665 Free PMC article.
-
High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia.PLoS One. 2023 Jun 27;18(6):e0287453. doi: 10.1371/journal.pone.0287453. eCollection 2023. PLoS One. 2023. PMID: 37368908 Free PMC article.
-
Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region, Ethiopia.Ann Clin Microbiol Antimicrob. 2021 Mar 11;20(1):16. doi: 10.1186/s12941-021-00422-1. Ann Clin Microbiol Antimicrob. 2021. PMID: 33706775 Free PMC article.
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
-
Prevalence of multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing gram-negative bacilli: A meta-analysis report in Ethiopia.Drug Target Insights. 2020 Oct 5;14:16-25. doi: 10.33393/dti.2020.2170. eCollection 2020. Drug Target Insights. 2020. PMID: 33132695 Free PMC article. Review.
Cited by
-
Antimicrobial resistance from one health perspective in the Middle East: A systematic review.Open Vet J. 2024 Jan;14(1):577-585. doi: 10.5455/OVJ.2024.v14.i1.53. Epub 2024 Jan 31. Open Vet J. 2024. PMID: 38633186 Free PMC article.
-
A National Surveillance of the Antibiotic Susceptibility of Acinetobacter baumannii in Saudi Arabia.Antibiotics (Basel). 2025 Feb 19;14(2):209. doi: 10.3390/antibiotics14020209. Antibiotics (Basel). 2025. PMID: 40001452 Free PMC article.
-
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.PLoS One. 2024 Dec 16;19(12):e0311124. doi: 10.1371/journal.pone.0311124. eCollection 2024. PLoS One. 2024. PMID: 39680587 Free PMC article.
-
Impact of Antimicrobial Therapy on Mortality and Readmission in Multidrug-Resistant Pseudomonas Infections: A Retrospective Study at Dammam Medical Complex.Cureus. 2024 Nov 30;16(11):e74870. doi: 10.7759/cureus.74870. eCollection 2024 Nov. Cureus. 2024. PMID: 39741620 Free PMC article.
-
Prevalence and genetic characterization of clinically relevant extended-spectrum β-lactamase-producing Enterobacterales in the Gulf Cooperation Council countries.Front Antibiot. 2023 Jun 26;2:1177954. doi: 10.3389/frabi.2023.1177954. eCollection 2023. Front Antibiot. 2023. PMID: 39816644 Free PMC article. Review.
References
-
- Kilpatrick M, Hutchinson A, Manias E, Bouchoucha SL. Paediatric nurses', children's and parents' adherence to infection prevention and control and knowledge of antimicrobial stewardship: A systematic review. American Journal of Infection Control. 2021;49(5):622–639. - PubMed
-
- Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ. Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet. 2016;387(10014):176–187. - PubMed
-
- WHO, author. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization; 2012.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical